1.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000602239, UZG-CUL-UHG-Non-InvasiveBladde, EU-20870, UZG-CUL-UHG-Non-InvasiveBladderCancer, CUL-UHG-Non-Invasive Bladder Cancer, NCT00729287
|
|
2.
|
Phase: Phase III Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
|
|
3.
|
Phase: Phase II Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: IRB00050273, NCT01489813
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: UOSG-AMC-0804, NCT01490437
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I 129408, NCI-2010-00759, NCT01108003
|
|
6.
|
Phase: No phase specified Type: Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 0S-08-9, NCT00936364
|
|
7.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Active Age: Over 18 to 80 Sponsor: Other Protocol IDs: J1236, NCT01826097
|